Neurocrine Biosciences shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $6.7M | 47k | 141.83 |
| 2025-09-30 | $7.9M | 56k | 140.38 |
| 2025-06-30 | $6.7M | 54k | 125.69 |
| 2025-03-31 | $6.4M | 58k | 110.60 |
| 2024-12-31 | $4.9M | 36k | 136.50 |
| 2024-09-30 | $3.6M | 31k | 115.22 |
| 2024-06-30 | $3.9M | 29k | 137.67 |
| 2024-03-31 | $4.6M | 33k | 137.92 |
| 2023-12-31 | $2.8M | 21k | 131.76 |
| 2023-09-30 | $5.8M | 52k | 112.50 |
| 2023-06-30 | $5.3M | 57k | 94.30 |
| 2023-03-31 | $4.7M | 47k | 101.22 |
| 2022-12-31 | $2.7M | 23k | 119.44 |
| 2022-09-30 | $2.5M | 24k | 106.22 |
| 2022-06-30 | $389k | 4.0k | 97.59 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management